Michael Ehlers, a former executive at Biogen and Pfizer, has assumed an advisory role in psychedelics research. Ehlers has followed the science of psychedelics for over a decade and is excited by the potential for therapeutic applications. MDMA and psilocybin have both been granted breakthrough therapy status by the FDA, signaling a shift in the future of mental health treatment.
— Read on bigthink.com/surprising-science/psychedelics-michael-ehlers